Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.7 USD | +0.60% | +0.52% | -5.74% |
02:36am | J&J must pay $260 million in latest talc trial, Oregon jury says | RE |
Jun. 03 | Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.74% | 356B | |
+42.60% | 748B | |
+33.32% | 598B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.87% | 245B | |
+8.48% | 211B | |
-4.38% | 209B | |
+6.74% | 165B | |
+1.81% | 166B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Strikes $16.6 Billion Deal to Buy Heart-Device Maker Abiomed